Chromane derivatives of small aromatic molecules: Chemoenzymatic synthesis and growth inhibitory activity on human tumor cell line LoVo WT

A Macone, E Lendaro, A Comandini, I Rovardi… - Bioorganic & medicinal …, 2009 - Elsevier
A Macone, E Lendaro, A Comandini, I Rovardi, RM Matarese, A Carraturo, A Bonamore
Bioorganic & medicinal chemistry, 2009Elsevier
Aromatic substrates tyrosol (p-hydroxyphenylethanol) and 2, 6-dihydroxynaphthalene (2, 6-
DHN) were converted into chromane derivatives by means of chemoenzymatic reactions
catalyzed by the aromatic prenyltransferase of bacterial origin NovQ, using dimethylallyl
bromide as allylic substrate instead of the natural isoprenyl pyrophosphate substrate.
Stereoselective prenylation occurred in o-position with respect to the phenol hydroxyl in both
compounds. Prenylated derivatives were readily converted into chromane products via a …
Aromatic substrates tyrosol (p-hydroxyphenylethanol) and 2,6-dihydroxynaphthalene (2,6-DHN) were converted into chromane derivatives by means of chemoenzymatic reactions catalyzed by the aromatic prenyltransferase of bacterial origin NovQ, using dimethylallyl bromide as allylic substrate instead of the natural isoprenyl pyrophosphate substrate. Stereoselective prenylation occurred in o-position with respect to the phenol hydroxyl in both compounds. Prenylated derivatives were readily converted into chromane products via a selective 6-endo-trig cyclization involving the oxygen atom from the phenol moiety and the double bond of the prenyl substituent, a process catalyzed by FeCl3. These findings set up the basis of a most convenient two-step, one-pot process which allows for easy recovery of the chromane products in high yields. The chromane derivatives thus obtained were tested for cytotoxicity and pro-apoptotic activity using LoVo WT cells, a line of human colon adenocarcinoma.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果